CD8A and cancer: Given their native role is to stimulate the migration of immune cells, co-opting these properties in order to facilitate the migration of cytotoxic effector cells, such as CD8+ T cells and NK cells, towards cancer cells can possibly increase the efficacy of current immunotherapy treatments.